Shawn K. Singh

2016

In 2016, Shawn K. Singh earned a total compensation of $2M as Chief Executive Officer at Vistagen Therapeutics, a 91% increase compared to previous year.

Compensation breakdown

Option Awards$1,629,574
Salary$347,500
Total$1,977,074

Singh received $1.6M in option awards, accounting for 82% of the total pay in 2016.

Singh also received $347.5K in salary.

Rankings

In 2016, Shawn K. Singh's compensation ranked 4,944th out of 14,075 executives tracked by ExecPay. In other words, Singh earned more than 64.9% of executives.

ClassificationRankingPercentile
All
4,944
out of 14,075
65th
Division
Manufacturing
1,764
out of 5,486
68th
Major group
Chemicals And Allied Products
556
out of 1,900
71st
Industry group
Drugs
412
out of 1,543
73rd
Industry
Pharmaceutical Preparations
327
out of 1,173
72nd
Source: SEC filing on August 5, 2016.

Singh's colleagues

We found two more compensation records of executives who worked with Shawn K. Singh at Vistagen Therapeutics in 2016.

2016

H Snodgrass

Vistagen Therapeutics

Chief Scientific Officer

2016

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

News

In-depth

You may also like